Molina Healthcare, Inc $MOH Stake Lifted by Aurora Investment Managers LLC.

Aurora Investment Managers LLC. grew its stake in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 118.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 38,576 shares of the company's stock after purchasing an additional 20,956 shares during the quarter. Molina Healthcare accounts for 5.4% of Aurora Investment Managers LLC.'s investment portfolio, making the stock its 4th biggest position. Aurora Investment Managers LLC. owned 0.07% of Molina Healthcare worth $8,822,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Torren Management LLC acquired a new position in Molina Healthcare during the 4th quarter worth approximately $26,000. Physician Wealth Advisors Inc. grew its position in Molina Healthcare by 1,250.0% in the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company's stock valued at $29,000 after acquiring an additional 200 shares in the last quarter. Quarry LP acquired a new stake in Molina Healthcare in the fourth quarter valued at approximately $32,000. SJS Investment Consulting Inc. raised its stake in shares of Molina Healthcare by 504.9% during the first quarter. SJS Investment Consulting Inc. now owns 248 shares of the company's stock valued at $33,000 after purchasing an additional 207 shares during the period. Finally, Elevation Wealth Partners LLC lifted its position in shares of Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company's stock worth $33,000 after purchasing an additional 78 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Molina Healthcare Trading Up 2.5%

Shares of NYSE MOH opened at $196.65 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. The stock's 50 day moving average price is $209.25 and its two-hundred day moving average price is $177.81. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $244.89. The stock has a market capitalization of $10.27 billion, a P/E ratio of -1,092.43, a PEG ratio of 27.49 and a beta of 0.75.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. The company had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business's revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the firm earned $5.48 EPS. On average, analysts anticipate that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

Analyst Ratings Changes

MOH has been the subject of a number of recent analyst reports. Cantor Fitzgerald reaffirmed a "neutral" rating on shares of Molina Healthcare in a report on Friday, July 24th. Royal Bank Of Canada cut their price objective on shares of Molina Healthcare from $248.00 to $218.00 and set a "sector perform" rating on the stock in a report on Friday, July 24th. TD Cowen upped their price objective on shares of Molina Healthcare from $163.00 to $230.00 and gave the company a "hold" rating in a research report on Tuesday, July 14th. UBS Group raised their target price on Molina Healthcare from $180.00 to $202.00 and gave the company a "neutral" rating in a research note on Friday, May 22nd. Finally, Truist Financial dropped their target price on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating on the stock in a research report on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and a consensus price target of $202.44.

Insider Transactions at Molina Healthcare

In related news, insider Jeff D. Barlow sold 17,811 shares of the business's stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by corporate insiders.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source